Atrial amyloidosis: mechanisms and clinical manifestations.

Amyloidosis Atrial disease Atrial fibrillation Heart Natriuretic peptides

Journal

European journal of heart failure
ISSN: 1879-0844
Titre abrégé: Eur J Heart Fail
Pays: England
ID NLM: 100887595

Informations de publication

Date de publication:
11 2022
Historique:
revised: 12 07 2022
received: 04 06 2022
accepted: 01 08 2022
pubmed: 4 8 2022
medline: 15 12 2022
entrez: 3 8 2022
Statut: ppublish

Résumé

Cardiac amyloidosis (CA) is now recognized as an important cause of heart failure. Increased wall thickness and diastolic dysfunction of the left ventricle are the most easily detectable manifestations of CA, but amyloid accumulates in all cardiac structures. Involvement of the left and right atria may be due to the haemodynamic effects of ventricular diastolic dysfunction, the effects of amyloid infiltration into the atrial wall, and the cardiotoxic damage of atrial cardiomyocytes by amyloid precursors. Atrial amyloidosis is an early manifestation of CA, and is associated with an increased risk of atrial fibrillation and thromboembolic events. Furthermore, atrial amyloidosis can be found even in the absence of systemic disease and ventricular involvement. This condition is named isolated atrial amyloidosis and is due to a local overproduction of atrial natriuretic peptide. In this review we summarize the evidence on the mechanisms and clinical relevance of atrial amyloidosis.

Identifiants

pubmed: 35920110
doi: 10.1002/ejhf.2650
pmc: PMC10087817
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2019-2028

Informations de copyright

© 2022 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

J Am Coll Cardiol. 2019 Feb 12;73(5):589-597
pubmed: 30732713
ESC Heart Fail. 2020 Dec;7(6):4305-4310
pubmed: 33012122
J Am Coll Cardiol. 2022 Apr 5;79(13):1288-1303
pubmed: 35361352
Eur Heart J Cardiovasc Imaging. 2022 Dec 19;24(1):130-141
pubmed: 35292807
JACC Cardiovasc Imaging. 2022 Jan;15(1):17-29
pubmed: 34419399
ESC Heart Fail. 2018 Oct;5(5):772-779
pubmed: 29916559
Eur Heart J. 2004 Jul;25(14):1237-41
pubmed: 15246642
Eur Heart J Cardiovasc Imaging. 2016 Sep;17(9):961-9
pubmed: 27194782
Eur J Heart Fail. 2021 Aug;23(8):1290-1295
pubmed: 33928732
Eur J Prev Cardiol. 2020 Nov;27(17):1806-1815
pubmed: 31581822
Br Heart J. 1965 Sep;27(5):711-8
pubmed: 5829755
Heart Rhythm. 2016 Feb;13(2):383-90
pubmed: 26400855
JACC Cardiovasc Imaging. 2021 Aug;14(8):1508-1519
pubmed: 33744146
Int J Cardiol Heart Vasc. 2020 Sep 14;31:100633
pubmed: 32995476
Eur Heart J. 2021 Dec 07;:
pubmed: 34875053
J Am Soc Echocardiogr. 2016 Nov;29(11):1092-1099.e2
pubmed: 27614542
Cell Death Dis. 2010 Nov 11;1:e98
pubmed: 21368874
J Am Coll Cardiol. 2016 Sep 20;68(12):1323-41
pubmed: 27634125
Amyloid. 2021 Mar;28(1):12-18
pubmed: 32981389
Amyloid. 2018 Jun;25(2):86-92
pubmed: 29529877
J Cardiovasc Electrophysiol. 2016 Oct;27(10):1167-1173
pubmed: 27422772
J Am Coll Cardiol. 2021 Jul 6;78(1):89-91
pubmed: 33957237
J Am Soc Echocardiogr. 2016 Apr;29(4):277-314
pubmed: 27037982
Can J Cardiol. 2020 Mar;36(3):322-334
pubmed: 32145862
Circulation. 2009 May 12;119(18):2490-7
pubmed: 19414641
Circulation. 1981 Jun;63(6):1285-8
pubmed: 7014028
Eur Heart J. 2006 Jul;27(14):1670
pubmed: 16449244
Amyloid. 2019 Sep;26(3):128-138
pubmed: 31172799
J Am Coll Cardiol. 2019 Apr 9;73(13):1733-1734
pubmed: 30947929
Heart Fail Rev. 2015 Mar;20(2):125-31
pubmed: 25597027
Eur J Heart Fail. 2021 Aug;23(8):1296-1299
pubmed: 34050585
Eur Heart J. 2022 Jan 31;43(4):342-344
pubmed: 34499721
Eur Heart J. 2008 Jan;29(2):212
pubmed: 17704093
J Am Coll Cardiol. 2019 Jun 11;73(22):2872-2891
pubmed: 31171094
Sci Rep. 2019 Nov 12;9(1):16584
pubmed: 31719596
Eur Heart J Cardiovasc Imaging. 2017 Oct 01;18(10):1128-1137
pubmed: 28637305
Rev Invest Clin. 2019;71(6):387-392
pubmed: 31823968
N Engl J Med. 1992 Nov 26;327(22):1570-3
pubmed: 1435884
Circulation. 2022 Feb;145(5):392-409
pubmed: 35100023
Int J Cardiol. 2018 Nov 15;271:152-160
pubmed: 30223349
Europace. 2020 Feb 1;22(2):259-264
pubmed: 32031230
Circulation. 2007 Nov 20;116(21):2420-6
pubmed: 17984380
Sci Rep. 2021 Feb 11;11(1):3563
pubmed: 33574429
Europace. 2004 Sep;6(5):433-7
pubmed: 15294268
Circ Arrhythm Electrophysiol. 2022 Mar;15(3):e010636
pubmed: 35212578
Int J Cardiovasc Imaging. 2021 Dec 27;:
pubmed: 34958452
Pathol Int. 1995 May;45(5):335-42
pubmed: 7647929
Amyloid. 2015;22(3):147-55
pubmed: 25997105
Circ Res. 2021 May 14;128(10):1554-1575
pubmed: 33983835
Circulation. 2002 Oct 15;106(16):2091-7
pubmed: 12379579
Eur Heart J. 2021 Apr 21;42(16):1554-1568
pubmed: 33825853
JACC Clin Electrophysiol. 2020 Sep;6(9):1118-1127
pubmed: 32972546
Circulation. 2020 Jul 7;142(1):e7-e22
pubmed: 32476490
Eur Heart J. 2019 Dec 1;40(45):3699-3706
pubmed: 31111153
Ann Intern Med. 1961 Dec;55:989-94
pubmed: 13877133
Eur Heart J Cardiovasc Imaging. 2018 Jun 1;19(6):630-638
pubmed: 29529180

Auteurs

Giuseppe Vergaro (G)

Interdisciplinary Center Health Science, Scuola Superiore Sant'Anna, Pisa, Italy.
Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Alberto Aimo (A)

Interdisciplinary Center Health Science, Scuola Superiore Sant'Anna, Pisa, Italy.
Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Claudio Rapezzi (C)

Cardiology Centre, University of Ferrara, Ferrara, Italy.
Maria Cecilia Hospital, GVM Care & Research, Ravenna, Italy.

Vincenzo Castiglione (V)

Interdisciplinary Center Health Science, Scuola Superiore Sant'Anna, Pisa, Italy.

Iacopo Fabiani (I)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Angela Pucci (A)

University Hospital of Pisa, Pisa, Italy.

Gabriele Buda (G)

University Hospital of Pisa, Pisa, Italy.

Claudio Passino (C)

Interdisciplinary Center Health Science, Scuola Superiore Sant'Anna, Pisa, Italy.
Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Josep Lupón (J)

Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Antoni Bayes-Genis (A)

Heart Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
CIBERCV, Instituto de Salud Carlos III, Madrid, Spain.

Michele Emdin (M)

Interdisciplinary Center Health Science, Scuola Superiore Sant'Anna, Pisa, Italy.
Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Eugene Braunwald (E)

Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH